GOLDMAN SACHS GROUP INC - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 68 filers reported holding CASI PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$20,000
-50.0%
24,468
-51.4%
0.00%
Q4 2021$40,000
-83.2%
50,396
-74.8%
0.00%
Q3 2021$238,000
+1.7%
199,986
+32.3%
0.00%
Q2 2021$234,000
+57.0%
151,183
+143.6%
0.00%
Q1 2021$149,000
+71.3%
62,052
+109.8%
0.00%
Q4 2020$87,000
-67.9%
29,579
-83.3%
0.00%
Q3 2020$271,000
+834.5%
176,631
+1419.9%
0.00%
Q2 2020$29,000
-50.8%
11,621
-60.1%
0.00%
Q1 2020$59,000
-60.1%
29,113
-39.2%
0.00%
Q4 2019$148,000
+26.5%
47,899
+37.3%
0.00%
Q3 2019$117,000
+101.7%
34,898
+91.9%
0.00%
Q2 2019$58,000
-39.6%
18,190
-45.6%
0.00%
Q1 2019$96,000
-18.6%
33,431
+14.7%
0.00%
Q4 2018$118,000
-11.3%
29,148
+2.2%
0.00%
Q3 2018$133,000
-82.1%
28,517
-84.0%
0.00%
Q1 2018$743,000
+1118.0%
178,063
+844.1%
0.00%
Q4 2017$61,000
+125.9%
18,861
-23.8%
0.00%
Q3 2016$27,000
-22.9%
24,751
-18.0%
0.00%
Q2 2016$35,00030,1790.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
IDG-Accel China Growth Fund III Associates L.P. 7,973,536$23,522,00027.18%
Consonance Capital Management LP 7,576,431$22,350,0002.09%
Wellington Shields & Co., LLC 1,812,769$5,348,0001.92%
Wellington Shields Capital Management, LLC 2,071,765$6,112,0000.82%
Ikarian Capital, LLC 1,268,154$3,741,0000.16%
Sio Capital Management, LLC 203,432$600,0000.12%
Zebra Capital Management LLC 11,182$33,0000.04%
FEDERATED HERMES, INC. 7,000,000$20,650,0000.04%
GSA CAPITAL PARTNERS LLP 52,146$154,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 161,949$478,0000.02%
View complete list of CASI PHARMACEUTICALS INC shareholders